◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › ACOG

Alpha Cognition Inc. (ACOG) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-26

Alpha Cognition Inc. (ACOG) operates in the Biotechnology industry and is headquartered in Grapevine, United States with about 71 employees. Its market capitalization is roughly $172 million. In the fiscal year ended 2025-12-31, ACOG reported $10M in revenue and ($21M) in net income.

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.

Interactive charts & full statements → Open the ACOG valuation workbench →

ACOG Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$10M$0M$0M$0M
Gross Profit$8M$0M
Operating Income (EBIT)($23M)($12M)($10M)($14M)
Net Income($21M)($15M)($14M)($12M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ACOG Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$4M$3M$3M$2M$3M
Gross Profit$3M$2M$2M$1M$2M
Operating Income (EBIT)($8M)($8M)($5M)($6M)($3M)
Net Income($6M)($7M)($1M)($10M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ACOG Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ACOG Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$80M$51M$2M$3M
Total Liabilities$17M$12M$7M$4M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ACOG viewer.

Other Companies in Biotechnology

← ACNTAll stocksACON →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.